All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsAdvancing the development of a novel compound for the treatment of inflammatory disease - Licensing Opportunity for Dublin City University - August 2017DCU and UCD have jointly identified a compound purified from a marine species that exerts potent anti-inflammatory activity. The mechanism of action has been elucidated and the team have shown that the intracellular targ... pdf 287KBEnduragel - a Novel Therapeutic Filling Material for Treatment of Cerebral Aneurysms - Licensing Opportuity for Dublin City University - August 2017 Enduragel, which is an injectable hydrogel for the treatment of brain aneurysms and other vascular problems such as Arteriovenous Malformations (AVMs) and dural fistulas. pdf 205.7KBNovel Panel of Breast Cancer Biomarkers - Licensing Opportunity for Dublin City University - August 2017We have identified a panel of serum biomarkers which when assayed along with CA15-3 can detect breast cancer in 90- 95% of cases tested. This is a major improvement over the existing CA 15-3 tests that are commercially a... pdf 212.7KBSEPTEC - Sepsis Detection Platform - Licensing Opportunity for Dublin City University - August 2017SepTec is a centrifugal microfluidic disk platform. Antibody based electrochemical sensor technology, in conjunction with microfluidic engineering allows sensitive and rapid detection of pathogens in a 2mL whole blood sa... pdf 258KBMemsense - Lipid Bilayer Membrane Model Platform for Drug Discovery - Licensing Opportunity for Dublin City University - August 2017MemSense is an advanced true lipid bilayer membrane platform developed as a cell membrane model for application in pre-formulation studies of new molecules and drug delivery vehicles in drug discovery in the pharmaceutic... pdf 274.3KB First 1234567891011121314151617181920212223242526272829 Last Print Bookmark Top